Neurotransmitter release in experimental stroke models: The role of glutamate-GABA interaction

Advances in Experimental Medicine and Biology

Volumn 541, Issue , 2003, Pages 21-37

  Harsing Jr , Laszlo G ^a   Gigler, Gabor ^a   Albert, Mihaly ^a   Szenasi, Gabor ^a   Simo, Annamaria ^a   Moricz, Krisztina ^a   Varga, Attila ^a   Ling, Istvan ^a   Bagdy, Erzsebet ^b   Kiraly, Istvan ^b   Solyom, Sandor ^b   Juranyi, Zsolt ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

^b TEVA PHARMACEUTICALS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 AMINOBUTYRIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; GLUTAMIC ACID;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL MODEL; ANOXIA; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN TISSUE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CORPUS STRIATUM; FRONTAL CORTEX; GABAERGIC TRANSMISSION; HISTOPATHOLOGY; HORMONE TRANSPORT; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE PROJECTION; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; STROKE;

ACTION POTENTIALS; ANIMALS; ANOXIA; BRAIN; CEREBROVASCULAR ACCIDENT; D-ASPARTIC ACID; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; NEURAL PATHWAYS; NEURONS; TETRAZOLIUM SALTS; TRITIUM;

ANIMALIA;

EID: 9144272334     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (45)

1. Abraham, G., Solyom, S., Csuzdi, E., Berzsenyi, P., Ling, I., Tarnawa, I., Hamori, T., Pallagi, I., Horvath, K., Andrasi, F., Kapus, G., Harsing, L. G., Jr., and Kiraly, I., 2000, New non competitive AMPA antagonists, Bioorg. Med. Chem. 8:2127.
2. Aghajanian, G. K., and Marek, G. J., 2000, Serotonin model of schizophrenia: emerging role of glutamate mechanisms, Brain Res. Rev. 31:302.
3. Baldwin, H. A., Williams, J. L., Snares, M., Ferriera, T., Cross, A. J., Green, A. R., 1994, Attenuation by chlormethiazole of the rise in extracellular amino acids following focal ischemia in the cerebral cortex of the rat, Br. J. Pharmacol. 112:188.
4. 3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs, Br. J. Pharmacol. 104:15.
5. Bederson, J. B., Pitts, L. H., Gremano, S. M., Nishimura, M. C., Davis, R. L., and Bartkowski, H. M., 1986, Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats, Stroke 17:1304.
6. Bolam, J.P., and Bennett, B. D., 1995, Microcircuitry of the neostriatum, in: Molecular and Cellular Mechanisms of Neurostriatal Function, M. A. Ariano, and D. J. Surmeier, EDS., Landes Company, Austin, TX, pp. 1-19.
7. Carlsson, A., Hansson, L. O., Waters, N., and Carlsson, M. L., 1997, Neurotransmitter aberration in schizophrenia: new perspectives and therapeutic implications, Life Sci. 61:75.
8. Chen, Q., Veenman, I., Knopp, K., Yan, Z., Medina, L., Song, W.-J., Surmeier, D. J., and Reiner, A., 1998, Evidence for the preferential location of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum, Neuroscience 83:749.
9. Coyle, J. T., Puttfarcken, P., 1993, Oxidative stress, glutamate and neurodegenerative disorders, Science 262:689.
10. Gajkowska, B., Mossakowski, M. J., 1994, Ischemia inhibits GABAergic neurons of the rat thalamic reticular nucleus. An immunocytochemical study, Folia Neuropathol, 32:139.
11. Gerfen, C. R., The neostriatal mosaic: multiple levels of compartmental organization, TINS 15:133.
12. Globus, M. Y.-Y., Busto, R., Martinez, E., Valdes, I., Dietrich, W. D., and Ginsberg, M. D., 1991, Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and γ-aminobutyric acid in vulnerable and non vulnerable brain regions in the rat, J. Neurochem. 57:470.
13. Gonzales, C., Lin, R. C.-S., and Chesselet, M.-F., 1992, Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions, Neurosci. Lett. 135:53.
14. Harsing, L. G., Jr., Sershen, H., Lajtha, A., 1992, Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization, J. Neurochem. 59:48.
15. Harsing, L. G., Jr., Zigmond, M. J., 1997, Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences, Neuroscience 77:419.
16. Harsing, L. G., Jr., Zigmond, M. J., 1998, Postsynaptic integration of cholinergic and dopaminergic signals on medium size GABAergic projection neurons in the neostriatum. Brain Res. Bull. 45:607.
17. 3H]GABA release in rat striatum, Neurochem. Internat. 37:33.
18. Iversen, L. L., and Kelly, J. S., 1975, Uptake and metabolism of γ-aminobutyric acid by neurones and glial cells, Biochem. Pharmac. 24:933.
19. Juranyi, Zs., Harsing, L. G., Jr., Zigmond, M. J., 2003, A new method for the investigation of transmitter release in complex corticostriatal slice preparation in vitro, J. Neurosci. Methods in press.
20. Katsura, M., Lino, T., and Kuriyama, K., 1992, Changes in content of neuroactive amino acids and acetylcholine in the rat hippocampus following transient forebrain ischemia, Neurochem. Int. 21:243.
21. Kawai, K., Penix, L. P., and Kawara, N., 1995, Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia, J. Cereb. Blood Flow Metab. 15:248.
22. Kita, H., 1996, Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparation. Neuroscience 70:925.
23. Leyden, P.D., 1997, GABA and neuroprotection, Int. Rev. Neurobiol. 40:233.
24. Longa, E. Z., Weinstein, P. R., Carlson S., and Cummins, R., 1989, Reversible middle cerebral artery occlusion craniectomy in rats, Stroke 28:84.
25. Martin, R. L., Lloyd, H. G.E., and Cowan, A. I., 1994, The early events of oxygen and glucose deprivation: setting the scene for neural death? TINS 17:251.
26. Miluseva, E., Doda, M., Pasztor, E., Lajtha, A., Sershen, H., and Vizi, E.S., 1992, Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions, J. Neurochem. 69:946.
27. Nelson, R. M., Green, A. R., Lambert, D. G., and Hainsworth, A. H., 2000, On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone, Br. J. Pharmacol. 130:1124.
28. Nitsch, C., Goping, G., and Klatzo, I., 1989, Preservation of GABAergic perykaria and boutons after transient ischemia in the gerbil hippocampal CA1 field, Brain Res. 495:243.
29. Parsons, C. G., Danysz, W., and Quack, G., 1998, Glutamate in CNS disorders as a target for drug development: An update, Drug News Perspect. 11:523.
30. Phillis, J. W., Smith-Barbour, M., Perkins, L. M., O'Regan M. H., 1993, GYKI 52466 and ischemia-evoked neurotransmitter amino acid release from rat cerebral cortex, NeuroReport 4:109.
31. Ren, Y., Li, X., and Xu, Z. C., 1997, Asymmetrical protection of neostriatal neurons against transient forebrain ischemia by unilateral dopamine depletion, Exp. Neurol. 146:250.
32. Rowley, H. L., Martin, K. F., Marsden, C. A., 1995, Determination of in vivo amino acid neurotransmitters y high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation, J. Neurosci. Methods, 54:93.
33. A neurotransmission and cerebral ischemia, J. Neurochem. 77:353.
34. Seif-El-Nasr, M., and Khattab, M., 2002, Influence of inhibition of adenosine uptake on the γ-aminobutyric acid level of the ischemic rat brain, Arzneim. Forsch./Drug Res. 52:353.
35. Smith A. D., Bolam, J. P., 1990, The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones, TINS 13: 259.
36. Snyder, G., Keller, R. W., Zigmond, M. J., 1990, Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals, J. Pharm. Exp. Ther. 253:867.
37. B site antagonist MRZ 2/ 576 in transient focal ischaemia in rats, Arzneim.-Forsch/Drug Res. 52:168.
38. Szatkowski, M., Attwell, D., 1994, Triggering and execution of neural death in brain ischaemia: two phases of glutamate release by different mechanisms, TINS 17:359.
39. Szerb, J. C., 1982, Effect of nipecotic acid, a γ-aminobutyric acid transport inhibitor, on the turnover and release of γ-aminobutyric acid in the rat cerebral cortex, J. Neurochem. 39:850.
40. Taguchi, T., Miyake, K., and Tanonnaka, K., 1993, Sustained changes in acetylcholine and amino acid contents of brain regions following microsphere embolism in rats, Jpn. J. Pharmacol. 62:269.
41. Tarnawa, I., Vizi, E. S., 1998, 2,3-Benzodiazepine AMPA antagonists, Rest. Neurol. Neurosci. 13:41.
42. Vizi, E. S., Mike, A., and Tarnawa, I., 1996 2,3-Benzodiazepines (GYKI 52466 and analogs): negative allosteric modulators of AMPA receptors, CNS Drug Reviews 2:91.
43. Warner, D. S., Martin, H., Ludwig, P., McAllister, A., Keane, J. F. W., and Weber, E., 1995, In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists, J. Cereb. Blood Flow and Metab. 15:188.
44. Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace A. A., and Stricker, E. M., 1990, Compensations after lesions of central dopaminergic neurons: some clinical and basic implication, TINS 13:290.
45. Zoli, M., Grimaldi, R., Ferrari, R., Zini I., and Agnati, L. F., 1997, Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats, Stroke 28:1049.